Skip to main content

FDA to Integrate IMMD s KeyMolnet with ArrayTrack to Review Data

NEW YORK, Nov. 21 (GenomeWeb News) - The US Food and Drug Administration will integrate its ArrayTrack tool with KeyMolnet, the Institute of Medicinal Molecular Design said Friday.

 

Integrating ArrayTrack and KeyMolnet allows FDA scientists to study drug efficacy and toxicity from pharmacogenomic data submissions.

 

Tokyo-based IMMD's KeyMolnet is a next-generation bioinformatics platform for scientists to examine the relationship between genes, molecules, pathways, and drugs through multi-dimensional perspectives. ArrayTrack is a microarray data-management, -analysis, and -interpretation system.

 

Financial details were not disclosed.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.